Document Detail


A case of cervical spine meningioma following etanercept use in a patient with RA.
MedLine Citation:
PMID:  19648944     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: A 70-year-old female with active rheumatoid arthritis (RA) was administered etanercept to treat active disease that persisted despite therapy with conventional DMARDs. After 18 months of etanercept therapy, her RA symptoms had improved; however, she developed quadriparesis. She presented to a specialist rheumatology clinic with weakness and numbness in her arms and legs; she also had difficulty in standing up and walking. INVESTIGATIONS: Physical examination, neurological examination, nerve conduction studies, measurement of serum inflammatory markers and autoantibodies, MRI of the cranium and cervical spine, and X-rays of the chest and hands. DIAGNOSIS: The patient underwent neurosurgery to resect a 1 x 2 cm mass in the cervical spine at C6-C7. Histopathologic examination of the excised mass revealed it to be a meningioma. MANAGEMENT: Etanercept was discontinued because of a possible association between the drug and development of meningioma; however, shortly afterwards the patient experienced a flare of RA symptoms. High-dose NSAIDs and prednisolone were administered, but the patient died because of gastric perforation. To our knowledge, this is the first report in the literature of meningioma developing following use of tumor necrosis factor inhibitor therapy, and the first to suggest a cause-effect relationship.
Authors:
Omer N Pamuk; Ferda Harmandar
Related Documents :
19450084 - A case-control study of anaemia in patients with rheumatoid arthritis treated with dise...
9557604 - Refractory anemia with severe dysplasia: clinical significance of morphological feature...
18609264 - The relationship between anti-cyclic citrullinated peptide and bone mineral density and...
11196534 - Stromelysin-1 (mmp-3) in synovial fluid of patients with rheumatoid arthritis has poten...
9789534 - Sd plasma in ttp and coagulation factor deficiencies for which no concentrates are avai...
11569694 - Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Nature reviews. Rheumatology     Volume:  5     ISSN:  1759-4804     ISO Abbreviation:  Nat Rev Rheumatol     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-03     Completed Date:  2009-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101500080     Medline TA:  Nat Rev Rheumatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  457-60     Citation Subset:  IM    
Affiliation:
Division of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey. omernpamuk@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Cervical Vertebrae
Fatal Outcome
Female
Humans
Immunoglobulin G / adverse effects*
Meningioma / chemically induced*
Receptors, Tumor Necrosis Factor
Spinal Cord Neoplasms / chemically induced*
Chemical
Reg. No./Substance:
0/Antirheumatic Agents; 0/Immunoglobulin G; 0/Receptors, Tumor Necrosis Factor; 185243-69-0/TNFR-Fc fusion protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Approaches to the targeting of treatment for osteoporosis.
Next Document:  Is rheumatoid arthritis really getting less severe?